Prdm12em1Ggn
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Prdm12em1Ggn |
| Name: |
PR domain containing 12; endonuclease-mediated mutation 1, G Gregory Neely |
| MGI ID: |
MGI:7451049 |
| Synonyms: |
Prdm12W160C |
| Gene: |
Prdm12 Location: Chr2:31530049-31545807 bp, + strand Genetic Position: Chr2, 21.85 cM
|
| Alliance: |
Prdm12em1Ggn page
|
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a G to C change resulting in a tryptophan to cysteine substitution at amino acid 160 (p.W160C). This corresponds to a congenital insensitivity to pain-causing variant identified in human.
(J:312689)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Prdm12 Mutation: |
23 strains or lines available
|
|
| Original: |
J:312689 Kokotovic T, et al., PRDM12 Is Transcriptionally Active and Required for Nociceptor Function Throughout Life. Front Mol Neurosci. 2021;14:720973 |
| All: |
1 reference(s) |
|